Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novavax

6.99
-0.1600-2.24%
Post-market: 6.990.00000.00%19:59 EDT
Volume:5.60M
Turnover:39.45M
Market Cap:1.13B
PE:2.35
High:7.18
Open:7.14
Low:6.91
Close:7.15
Loading ...
Dec 04, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Oct 16, 2024

Major Issues Report

Form 8-K - Current report
Oct 03, 2024

Major Issues Report

Form 8-K - Current report
Sep 18, 2024

Proposed Sale Of Securities

Form 144 | NOVAVAX's Officer Filip Dubovsky proposes to sell 7335 Shares, with a total value of approximately $95331.
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 20, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jun 18, 2024

Proposed Sale Of Securities

Form144|Novavax Inc's Director James F.Young proposes to sell 15000 Shares, with a total value of approximately $205,650.
Jun 17, 2024

Proposed Sale Of Securities

Form144|Novavax's Officer Filip Dubovsky proposes to sell 13904 Shares, with a total value of approximately $201,185.
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities